Naomi Schlesinger - Publications, H-index & Citations

Naomi Schlesinger

school of medicine

46H指数

253论文数

6.9K被引数

收录论文 81

发表时间

Physician burnout in rheumatology: are medical scribes part of the solution?风湿病学中的医师职业倦怠：医疗文书人员是解决方案的一部分吗？

Clinical Rheumatology

IF2.8

2026-08-10

PREAI

Naomi Schlesinger; Dan Kaufmann; Mike Workman; Sonia L. Sugg; Jacob Stever; Richard S. Panush

Is Gout an Autoinflammatory Disease?痛风是一种自身炎症性疾病吗？

Current Rheumatology Reports

IF3.9

2026-03-21

PREAI

Naomi Schlesinger; Dan Kaufmann

COVID-19 Vaccination Is Not Associated With the Development of Idiopathic Inflammatory Myositis in US Veterans COVID-19疫苗接种与美军退伍军人特发性炎性肌病的发生无关

ARTHRITIS CARE & RESEARCH

IF3.3

2026-03-01

OAAI

Hernandez, Caleb; Schlesinger, Naomi; Rojas, Jorge; Walsh, Jessica A.; Braaten, Tawnie J.; Kunkel, Gary A.; Jones, Makoto; Sauer, Brian C.; Facelli, Julio; Cannon, Grant W.; Lebiedz-Odrobina, Dorota

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) in Uncontrolled Gout: Current Status and Future Directions 纳米胶囊西罗莫司加Pegadricase (NASP) 治疗不受控制的痛风: 现状和未来方向

Drugs

IF14.4

2026-02-03

OAAI

Herbert S. B. Baraf; Naomi Schlesinger; Vibeke Strand

New Use for an Old Medication: Colchicine, a Novel Therapeutic for Renoprotection 旧药新用：秋水仙碱，一种新型肾脏保护疗法

Current Pharmacology Reports

IF2.2

2025-12-04

PREAI

Schlesinger, Naomi; Cheung, Alfred K.; Brunetti, Luigi; Raphael, Kalani L.; Beddhu, Srinivasan

Could Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Play a Role in Gout Treatment?钠-葡萄糖协同转运蛋白-2抑制剂和胰高血糖素样肽-1受体激动剂在痛风治疗中能发挥作用吗？

pharmaceutics

IF0

2025-07-27

OAAI

Dan Kaufmann; Naomi Schlesinger

Incidence of gout diagnosis among participants with hyperuricemia, insights from a nationwide cohort study 高尿酸血症参与者中痛风诊断的发生率：一项全国性队列研究的见解

Seminars in Arthritis and Rheumatism

IF4.4

2025-06-12

OAAI

Shay Brikman; Oriel Perets; Liel Serfaty; Ran Abuhasira; Naomi Schlesinger; Snait Ayalon; Amir Bieber; Nadav Rappoport

Gastrointestinal Perforation as a Safety Concern Among Patients With Rheumatoid Arthritis Receiving JAK Inhibitor Therapy: A Systematic Review and Network Meta-Analysis 接受JAK抑制剂治疗的风湿性关节炎患者中，胃肠道穿孔作为一项安全问题的系统评价和网络荟萃分析

Arthritis Care & Research

IF3.3

2025-06-02

PREAI

Thipsukhon Sathapanasiri; Manuel Meraz; Hamraz Mokri; Sajesh K Veettil; Karn Wijarnpreecha; Naomi Schlesinger; Arthur Kavanaugh; Nathorn Chaiyakunapruk

Optimizing gout treatment: A comprehensive review of current and emerging uricosurics

JOINT BONE SPINE

IF4.3

2025-03-01

PREAI

Kaufmann, Dan; Chaiyakunapruk, Nathorn; Schlesinger, Naomi

Gout flare prophylaxis trials: comment on the article by Maher et al 痛风发作预防试验：对Maher等人文章的评论

Arthritis Care & Research

IF3.3

2025-01-16

PREAI

Naomi Schlesinger; Jamie Dwyer; Jeffrey Carson; Luigi Brunetti

Controversies and practical management of patients with gout and chronic kidney disease

KIDNEY INTERNATIONAL

IF12.6

2024-10-01

PREAI

Johnson, Richard J.; Mandell, Brian F.; Schlesinger, Naomi; Mount, David B.; Botson, John K.; Abdellatif, Abdul Ali; Rhoades, Robert; Singh, Jasvinder A.

EXAMINING THE QUALITY OF SURVEYS USED IN RHEUMATOLOGY HEALTH PROFESSIONS EDUCATION RESEARCH 调查风湿病学健康专业教育研究中使用的调查问卷质量

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

O'sullivan, M.; Battistone, M.; Barker, A.; Schlesinger, N.

Mechanisms and rationale for uricase use in patients with gout

NATURE REVIEWS RHEUMATOLOGY

IF32.7

2023-09-08

PREAI

Schlesinger, Naomi; Perez-Ruiz, Fernando; Liote, Frederic